# Mediview XR

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mediview-xr

- Industry: Medical Devices & Equipment
- Headquarters: Cleveland, US
- Website: www.mediview.com
- Total disclosed funding: $19M
- Latest round: Series A (Dec 31, 2024)
- Investors on record: 8

## About

Mediview XR, Inc. is a US-based medical technology company specializing in augmented reality solutions to enhance imaging and navigation in healthcare, aiming to improve procedural efficiency and patient outcomes. Founded in 2017 and headquartered in Cleveland, US, Mediview XR, Inc. focuses on augmented reality applications for medical environments. Its founder, Adam Rakestraw, has a history of innovation in the healthcare sector. In October 2025, Mediview XR, Inc. raised USD 24 million in series A funding led by returning investor GE Healthcare, with participation from other returning investors Cleveland Clinic Ventures, Mayo Clinic Ventures, JobsOhio. New investor Edge also participated in the round. Mediview XR, Inc. specializes in augmented reality (AR) solutions for medical imaging and navigation, primarily focused on enhancing procedural efficiency and outcomes in healthcare. The company’s flagship products include the OmnifyXR® Interventional Suite and the XR90 System, both designed to provide real-time imaging and intuitive visualization capabilities. OmnifyXR® seamlessly integrates into existing interventional suites, allowing clinicians to leverage augmented reality to improve workflow, ergonomics, and collaborative care during medical procedures. The XR90 System, a pioneering AR visualization and navigation tool, delivers 3D views of a patient’s internal anatomy specifically for minimally invasive, needle-based procedures. These products cater to a broad spectrum of healthcare institutions, including leading hospitals and academic medical centers, particularly in healthcare markets across North America and Europe, where they enhance clinical practices in interventional radiology and surgical navigation.Mediview XR, Inc. generates revenue through direct sales of its augmented reality products and solutions, primarily sold to hospitals and healthcare providers. The transaction structure typically involves direct-to-business sales, where healthcare institutions purchase the OmnifyXR® and XR90 systems as capital equipment for their facilities. Additionally, the company may offer subscription-based services or software updates that facilitate ongoing support and enhancements to their technological offerings. The primary revenue stream is derived from the sale of their proprietary systems, which are integral to modernizing surgical and interventional procedures. Through strategic partnerships with prominent healthcare providers, such as Cleveland Clinic and GE HealthCare, Mediview aims to expand its market reach and establish itself as a leader in healthcare innovation. The company plans to utilize the October 2025 funding to expand adoption of its AR clinical solutions, grow industry partnerships, and advance clinical validation and regulatory approvals.

## Funding rounds

- Series A, Dec 31, 2024, $14M — Mayo Clinic Ventures, GE Healthcare, JobsOhio, Cleveland Clinic Ventures, Edge
- Seed, Oct 21, 2019, $4.5M — Northwest Ohio Venture Fund, InsideView Inc., Plug and Play

## Investors

- Northwest Ohio Venture Fund (https://capitalatlas.ai/funds/northwest-ohio-venture-fund) — Seed
- InsideView Inc. — Seed
- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Seed
- Mayo Clinic Ventures (https://capitalatlas.ai/funds/mayo-clinic-ventures) — Series A
- GE Healthcare — Series A
- JobsOhio (https://capitalatlas.ai/funds/jobsohio) — Series A
- Cleveland Clinic Ventures (https://capitalatlas.ai/funds/cleveland-clinic-ventures) — Series A
- Edge (https://capitalatlas.ai/funds/edge) — Series A